1. Home
  2. FTHM vs FEMY Comparison

FTHM vs FEMY Comparison

Compare FTHM & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$0.96

Market Cap

42.4M

Sector

Finance

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.49

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHM
FEMY
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.4M
37.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
FTHM
FEMY
Price
$0.96
$0.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$2.50
$6.83
AVG Volume (30 Days)
230.6K
1.1M
Earning Date
03-11-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$421,612,000.00
$2,061,502.00
Revenue This Year
$30.07
$64.02
Revenue Next Year
$14.66
$147.19
P/E Ratio
N/A
N/A
Revenue Growth
32.78
63.53
52 Week Low
$0.65
$0.31
52 Week High
$3.37
$1.80

Technical Indicators

Market Signals
Indicator
FTHM
FEMY
Relative Strength Index (RSI) 32.67 32.72
Support Level $1.25 $0.53
Resistance Level $1.30 $0.56
Average True Range (ATR) 0.11 0.05
MACD -0.04 -0.01
Stochastic Oscillator 3.85 2.94

Price Performance

Historical Comparison
FTHM
FEMY

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: